Two common blood pressure drugs are not tied to increased risk of COVID-19
Research published in the peer-reviewed journal
The Lancet Digital Health and co-led by a UCLA Fielding School of Public Health faculty member has found that two widely used types of blood pressure drugs are not tied to an increased risk of COVID-19 infection or complications.
The international team co-led by Dr. Marc Suchard, UCLA Fielding School professor of biostatistics, found that there was no increased risk of COVID-19 diagnosis, hospitalization, or subsequent complications for users of either angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs). The study, the world s largest, examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives, researchers said.